Literature DB >> 32767944

Insights into Machine Learning-based Approaches for Virtual Screening in Drug Discovery: Existing Strategies and Streamlining Through FP-CADD.

Waqar Hussain1, Nouman Rasool1, Yaser Daanial Khan2.   

Abstract

BACKGROUND: Machine learning is an active area of research in computer science by the availability of big data collection of all sorts prompting interest in the development of novel tools for data mining. Machine learning methods have wide applications in computer-aided drug discovery methods. Most incredible approaches to machine learning are used in drug designing, which further aid the process of biological modelling in drug discovery. Mainly, two main categories are present which are Ligand-Based Virtual Screening (LBVS) and Structure-Based Virtual Screening (SBVS), however, the machine learning approaches fall mostly in the category of LBVS.
OBJECTIVES: This study exposits the major machine learning approaches being used in LBVS. Moreover, we have introduced a protocol named FP-CADD which depicts a 4-steps rule of thumb for drug discovery, the four protocols of computer-aided drug discovery (FP-CADD). Various important aspects along with SWOT analysis of FP-CADD are also discussed in this article.
CONCLUSION: By this thorough study, we have observed that in LBVS algorithms, Support Vector Machines (SVM) and Random Forest (RF) are those which are widely used due to high accuracy and efficiency. These virtual screening approaches have the potential to revolutionize the drug designing field. Also, we believe that the process flow presented in this study, named FP-CADD, can streamline the whole process of computer-aided drug discovery. By adopting this rule, the studies related to drug discovery can be made homogeneous and this protocol can also be considered as an evaluation criterion in the peer-review process of research articles. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  FP-CADD; Machine learning; computational biology; computational modelling; drug designing; drug discovery

Mesh:

Year:  2021        PMID: 32767944     DOI: 10.2174/1570163817666200806165934

Source DB:  PubMed          Journal:  Curr Drug Discov Technol        ISSN: 1570-1638


  6 in total

1.  Biological perspective of thiazolide derivatives against Mpro and MTase of SARS-CoV-2: Molecular docking, DFT and MD simulation investigations.

Authors:  Nouman Rasool; Farkhanda Yasmin; Shalini Sahai; Waqar Hussain; Hadiqa Inam; Arooj Arshad
Journal:  Chem Phys Lett       Date:  2021-03-06       Impact factor: 2.328

2.  Identification of stress response proteins through fusion of machine learning models and statistical paradigms.

Authors:  Ebraheem Alzahrani; Wajdi Alghamdi; Malik Zaka Ullah; Yaser Daanial Khan
Journal:  Sci Rep       Date:  2021-11-05       Impact factor: 4.379

Review 3.  From Data to Knowledge: Systematic Review of Tools for Automatic Analysis of Molecular Dynamics Output.

Authors:  Hanna Baltrukevich; Sabina Podlewska
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

4.  Deep Learning Approaches for Detection of Breast Adenocarcinoma Causing Carcinogenic Mutations.

Authors:  Asghar Ali Shah; Fahad Alturise; Tamim Alkhalifah; Yaser Daanial Khan
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

5.  Virtual Screening of Phytochemicals by Targeting HR1 Domain of SARS-CoV-2 S Protein: Molecular Docking, Molecular Dynamics Simulations, and DFT Studies.

Authors:  Arshia Majeed; Waqar Hussain; Farkhanda Yasmin; Ammara Akhtar; Nouman Rasool
Journal:  Biomed Res Int       Date:  2021-05-20       Impact factor: 3.411

6.  Machine learning approaches to optimize small-molecule inhibitors for RNA targeting.

Authors:  Hadar Grimberg; Vinay S Tiwari; Benjamin Tam; Lihi Gur-Arie; Daniela Gingold; Lea Polachek; Barak Akabayov
Journal:  J Cheminform       Date:  2022-02-02       Impact factor: 5.514

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.